Amsterdam, J. D., Fawcett, J., Quitkin, F. M., et al (1997) Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. American Journal of Psychiatry, 154, 963–969.
Demyttenaere, K. (1997) Compliance during treatment with antidepressants. Journal of Affective Disorders, 43, 27–39.
Fava, M., Rosenbaum, J., Hoog, S. L., et al (1998) A comparison of symptoms following treatment interruption: evidence from a randomized, double-blind trial with fluoxetine, sertraline, and paroxetine. European Psychiatry, 13 (suppl. 4), 204.
Grof, P., Joffe, R., Kennedy, S., et al (1993) An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression. International Clinical Psychopharmacology, 8, 167–172.
Hamilton, M. A. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–296.
Hodges, J. L. & Lehmann, E. I. (1963) Estimates of location based on rank tests. The Annals of Mathematical Statistics, 34, 598–611.
Kilpatrick, G. J., Bunce, K. T. & Tyers, M. B. (1990) 5-HT3 receptors. Medicinal Research Reviews, 10, 441–475.
Nielsen, O. A., Morsing, I., Petersen, J. S., et al (1991) Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements. Acta Psychiatrica Scandinavica, 84, 233–241.
Noyes, R. Jr, Garvey, M. J., Cook, B., et al (1991) Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry, 148, 517–523.
Prescott, R. J. (1981) The comparison of success rates in cross-over trials in the presence of an order effect. Applied Statistics, 30, 9–15.
Price, J. S., Waller, P. C., Wood, S. M., et al (1996) A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. British Journal of Clinical Pharmacology, 42, 757–763.
Richelson, E. (1996) Synaptic effects of antidepressants. Journal of Clinical Psychopharmacology, 16 (suppl. 2), 1–7.
Richelson, E. (1998) Serotonin: and what about its side effects?
Depression and Anxiety, 7 (suppl. 1), 18–20.
Rickels, K., Fox, I. L., Greenblatt, D. J., et al (1988) Clorazepate and lorazepam: clinical improvement and rebound anxiety. American Journal of Psychiatry, 145, 312–317.
Rosenbaum, J. F., Fava, M., Hoog, S. L., et al (1998) Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biological Psychiatry, 44, 77–87.
Schweizer, E., Rickels, K., Case, W. G., et al (1990) Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Archives of General Psychiatry, 47, 908–915.
Spielberger, C. D. (1983) Manual for the State Trait Anxiety Inventory.
Palo Alto, CA: Consulting Psychologists.
Zajecka, J., Fawcett, J., Amsterdam, J., et al (1998) Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. Journal of Clinical Psychopharmacology, 18, 193–197.